Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Richard H. Weisler"'
Publikováno v:
Neuropsychiatric disease and treatment. 18
Primary care clinicians have a vital role to play in the diagnosis and management of patients with major depressive disorder (MDD). This includes screening for MDD as well as identifying other possible psychiatric disorders including bipolar disorder
Publikováno v:
Current Psychiatry. 20
Autor:
Joan Gu, Manisha Madhoo, Matthew Dauphin, Olga Brawman-Mintzer, Roger S. McIntyre, Rajnish Mago, Dan V. Iosifescu, Brooke Geibel, Elias Sarkis, Cynthia Richards, Richard H. Weisler
Publikováno v:
Journal of Clinical Psychopharmacology
Supplemental digital content is available in the text.
Purpose/Background Psychostimulant augmentation is considered a potential treatment strategy for individuals with major depressive disorder who do not adequately respond to antidepressant mo
Purpose/Background Psychostimulant augmentation is considered a potential treatment strategy for individuals with major depressive disorder who do not adequately respond to antidepressant mo
Publikováno v:
The Journal of Clinical Psychiatry. 78:1351-1362
Publikováno v:
Clinical Pharmacology in Drug Development. 7:160-167
Extended-release methylphenidate is a first-line treatment for attention-deficit/hyperactivity disorder. A methylphenidate extended-release orally disintegrating tablet (MPH XR-ODT) has recently been developed. Here we report an open-label, randomize
Autor:
John L. Beyer, Richard H. Weisler
Publikováno v:
Psychiatric Clinics of North America. 39:111-123
Suicide behaviors (ideation, attempts, and completions) are unfortunately common in patients with bipolar disorder. It is estimated that 25 to 50% attempt suicide at least once during their lifetime, and 6% to 19% complete suicide. Risk factors inclu
Autor:
Roger M. Lane, Anne Torbeyns, Arif Khan, Boadie W. Dunlop, Delphine Hennicken, Craig Nelson, Richard H. Weisler, Michael E. Thase, Ming Zheng, Sanjay J. Mathew, Richard C. Shelton, Zubin Bhagwagar
Publikováno v:
Journal of Clinical Psychopharmacology. 35:454-459
Two phase 2B, randomized, double-blind studies assessed the efficacy and safety of fixed or flexible dose of triple monoamine uptake inhibitor BMS-820836 in patients with treatment-resistant depression to demonstrate whether switching to BMS-820836 w
Autor:
Valerie Arnold, Richard H. Weisler, Ming Yu, Brigitte Robertson, Margo Jaffee, Brian Yan, Michael Greenbaum
Publikováno v:
CNS Drugs
Objective The objective of this randomized, double-blind, placebo-controlled study was to evaluate the efficacy and safety of SHP465 mixed amphetamine salts (MAS) in adults with attention-deficit/hyperactivity disorder (ADHD). Methods Eligible adults
Publikováno v:
Postgraduate Medicine. 126:31-41
The relationship between attention-deficit/hyperactivity disorder (ADHD) symptoms and global clinical assessment of functionality is complex. This post-hoc analysis explores this relationship and suggests implications for patient assessment in clinic
Publikováno v:
The Journal of Clinical Psychiatry. 75:520-527
Objective To prospectively analyze effects of extended release quetiapine fumarate (quetiapine XR) on suicidality in major depressive disorder (MDD). Method Data were pooled from randomized, acute studies (4 monotherapy; 2 adjunct therapy) in adult p